Dallah Healthcare Co. signed a binding share purchase agreement (SPA) with Soliman Abdel Kader Fakeeh Hospital Co. (Fakeeh Care) to sell its entire 31.21% stake in Dr Mohammed bin Rashed Al-Faqih Partners Co. for a total cash consideration of SAR 497.98 million.
Under the agreement, the buyer (Fakeeh Care) will acquire 100% of the target company from all current shareholders, including Dallah Health, for a total transaction value of SAR 1.60 billion, of which Dallah’s share amounts to SAR 497.98 million. Upon completion, the buyer will own the entire share capital of the target company. 
Dallah Health stated in a statement to Tadawul the completion of the transaction remains subject to several conditions precedent, including obtaining clearance from the General Authority for Competition (GAC), securing approvals from certain counterparties of the target company, and the absence of any regulatory restrictions preventing the deal, among other agreed conditions.
Dallah Healthcare Co. signed a binding share purchase agreement (SPA) with Soliman Abdel Kader Fakeeh Hospital Co. (Fakeeh Care) to sell its entire 31.21% stake in Dr Mohammed bin Rashed Al-Faqih Partners Co. for a total cash consideration of SAR 497.98 million.
Under the agreement, the buyer (Fakeeh Care) will acquire 100% of the target company from all current shareholders, including Dallah Health, for a total transaction value of SAR 1.60 billion, of which Dallah’s share amounts to SAR 497.98 million. Upon completion, the buyer will own the entire share capital of the target company.
Dallah Health stated in a statement to Tadawul the completion of the transaction remains subject to several conditions precedent, including obtaining clearance from the General Authority for Competition (GAC), securing approvals from certain counterparties of the target company, and the absence of any regulatory restrictions preventing the deal, among other agreed conditions.
